Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3917 results

Sort By:

Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma

Study ID: NCT06045195
Start Date: 2025-08
End Date: 2029-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Pembrolizumab

Sponsor

University of Cologne

Source: clinicaltrials.gov

Share:
Add to list

Mindfulness and Behavior Change to Improve Cardiovascular Health of Older People With HIV

Study ID: NCT06001814
Start Date: 2025-09-08
End Date: 2028-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

One-Mind One-Heart

Education

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Argon Plasma Treatment for Ovarian Endometrioma Compared to Standard Cystectomy

Study ID: NCT07065214
Start Date: 2025-09-01
End Date: 2027-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

72

Intervention / Treatment

APC

Lap bipolar forceps

Sponsor

Erbe Elektromedizin GmbH

Source: clinicaltrials.gov

Share:
Add to list

Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

Study ID: NCT06968195
Start Date: 2025-07-30
End Date: 2029-05-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

Anti-GPC3-CAR Autologous T Lymphocytes

Biospecimen Collection

Computed Tomography

Cyclophosphamide

Echocardiography Test

Fludarabine

Leukapheresis

Magnetic Resonance Imaging

Multigated Acquisition Scan

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters!

Study ID: NCT06745050
Start Date: 2025-09
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

350

Intervention / Treatment

Text message mHealth Evidence-based intervention

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma

Study ID: NCT07067450
Start Date: 2025-07-20
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

98

Intervention / Treatment

Immune Checkpoint Inhibitors ( pembrolizumab, tislelizumab, sintilimab, camrelizumab, and toripalimab)

Observation

Sponsor

Sichuan University

Source: clinicaltrials.gov

Share:
Add to list

Structural and Intermediary Social Determinants of Oral Health Among Egyptian Women

Study ID: NCT04138550
Start Date: 2025-12-01
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment
Sponsor

Misr International University

Source: clinicaltrials.gov

Share:
Add to list

Imaging Depression in Parkinson's Disease

Study ID: NCT06402955
Start Date: 2025-12-01
End Date: 2029-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

11C-UCB-J

ketamine hydrochloride

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

Study for Patients With Hairy Cell Leukemia to Test the Targeted Agent Tovorafenib in Combination With Rituximab and Compare the Combination With Current Standard Treatment

Study ID: NCT06965114
Start Date: 2025-09-30
End Date: 2030-03-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

78

Intervention / Treatment

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Cladribine

Computed Tomography

Rituximab

Freight

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

The Role of GABA-mediated Inhibition in Multisensory Temporal Processing & Postural Control in Older Adults

Study ID: NCT03328455
Start Date: 2025-12-01
End Date: 2031-11-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Inhibitory control training

Knowledge-based training

Sponsor

University of Nevada, Reno

Source: clinicaltrials.gov

Share:
Add to list